Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Epstein

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
The Annals of Pharmacotherapy|February 11, 2005
Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populationsBenjamin J Epstein, John G Gums
Pharmacotherapy|June 28, 2005
Can the renin-angiotensin system protect against stroke? A focus on angiotensin II receptor blockersBenjamin J Epstein, John G Gums
The Journal of Cardiovascular Nursing|August 27, 2009
Optimizing management of hypertension with combination therapy: considerations for the nurse practitionerMary Ellen Roberts, Benjamin J Epstein
Current Pharmaceutical Design|January 20, 2009
Actions of selected cardiovascular hormones on arterial stiffness and wave reflectionsWilmer W Nichols, Benjamin J Epstein
Drugs|September 16, 2005
Optimal pharmacological therapy for community-acquired pneumonia: the role of dual antibacterial therapyBenjamin J Epstein, John G Gums
American Journal of Therapeutics|July 29, 2009
Managing peripheral edema in patients with arterial hypertensionBenjamin J Epstein, Mary Ellen Roberts
Postgraduate Medicine|May 14, 2010
How to obtain appropriate type 2 diabetes control in the first 180 days of treatment initiationLouis Kuritzky, Benjamin J Epstein, Frank Lavernia
The New England Journal of Medicine|February 3, 2007
Effect of ramipril on the incidence of diabetesBenjamin J Epstein, Rhonda M Cooper-DeHoff
The Annals of Pharmacotherapy|September 2, 2004
The changing face of antibiotic prescribing: the mutant selection windowBenjamin J Epstein, John G Gums, Karl Drlica
Expert Review of Cardiovascular Therapy|November 9, 2011
Less RAAS is more, or notNiren K Shah, Rushab Choksi, Benjamin J Epstein
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The Annals of Pharmacotherapy|February 11, 2005
Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populationsBenjamin J Epstein, John G Gums
Pharmacotherapy|June 28, 2005
Can the renin-angiotensin system protect against stroke? A focus on angiotensin II receptor blockersBenjamin J Epstein, John G Gums
The Journal of Cardiovascular Nursing|August 27, 2009
Optimizing management of hypertension with combination therapy: considerations for the nurse practitionerMary Ellen Roberts, Benjamin J Epstein
Current Pharmaceutical Design|January 20, 2009
Actions of selected cardiovascular hormones on arterial stiffness and wave reflectionsWilmer W Nichols, Benjamin J Epstein
Drugs|September 16, 2005
Optimal pharmacological therapy for community-acquired pneumonia: the role of dual antibacterial therapyBenjamin J Epstein, John G Gums
American Journal of Therapeutics|July 29, 2009
Managing peripheral edema in patients with arterial hypertensionBenjamin J Epstein, Mary Ellen Roberts
Postgraduate Medicine|May 14, 2010
How to obtain appropriate type 2 diabetes control in the first 180 days of treatment initiationLouis Kuritzky, Benjamin J Epstein, Frank Lavernia
The New England Journal of Medicine|February 3, 2007
Effect of ramipril on the incidence of diabetesBenjamin J Epstein, Rhonda M Cooper-DeHoff
The Annals of Pharmacotherapy|September 2, 2004
The changing face of antibiotic prescribing: the mutant selection windowBenjamin J Epstein, John G Gums, Karl Drlica
Expert Review of Cardiovascular Therapy|November 9, 2011
Less RAAS is more, or notNiren K Shah, Rushab Choksi, Benjamin J Epstein
Pageof 3